<SEC-DOCUMENT>0001140361-20-013521-index.html : 20200610 <SEC-HEADER>0001140361-20-013521.hdr.sgml : 20200610 <ACCEPTANCE-DATETIME>20200610163215 ACCESSION NUMBER: 0001140361-20-013521 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20200610 DATE AS OF CHANGE: 20200610 EFFECTIVENESS DATE: 20200610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-239077 FILM NUMBER: 20955026 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>forms8.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: forms8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ex5_1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: ex5_1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ex23_1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: ex23_1.htm
</DOCUMENT> </SEC-DOCUMENT>